Purchase Order 36C24E24P0016
Award Date 1/22/24
Potential Completion Date 1/21/25
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $95,955 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a GRIDION MK1 sequencing machine. The sole source award is in response to solicitation 6505 for the intent to acquire a GridION Mk1 sequencing device from Nanopore Technologies for the James J. Peters VA Medical Center in Bronx, New York. The sequencing machine and associated assurance, software license,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a purchase order contract valued at one hundred thirty-two thousand sixty-two dollars to Oxford Nanopore Technologies Inc. for the acquisition of Oxford Nanopore sequencing devices and associated training and support. Per the solicitation, the Central Texas Veterans Health Care System Research Department sought to procure an Oxford Nanopore GridION sequencing device and PromethION...
- Oxford Nanopore Technologies Inc. was awarded a $104,675 purchase order by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs, for nanopore reagents on August 22, 2024. The contract utilizes a firm fixed-price structure with an ultimate completion date of August 2, 2025, and no set-aside designation was applied. The place of performance is located in New York, NY. These reagents support Oxford Nanopore's advanced genomic sequencing...
- This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
- The Department of Veterans Affairs, James J. Peters VA Medical Center has awarded a $23,050 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, for the PromethION 2 Solo CapEx sequencing device to support the SeqCURES research laboratory. This procurement was conducted as a sole source under FAR 13.106-1(b)(1)(ii) due to the unique technical capabilities of Oxford Nanopore's sequencing platforms. Oxford Nanopore has secured...
- The National Heart, Lung and Blood Institute's DNA Sequencing and Genomics Core awarded a $12,500 firm fixed price purchase order to Oxford Nanopore Technologies Inc. to provide a GridION license and warranty for the sequencing device identified as GXB03004. As a foreign owned, for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing technology and delivers the GridION and PromethION sequencing platforms, MINION flow cells, and complementary reagents and kits to...
- This is a $12,500 firm-fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS) to Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company, for a software license and warranty for a GridION system. The period of performance is from February 1, 2023, to January 31, 2024. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic sequencing equipment, consumables, reagents, software licenses, and associated services to...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...
- Oxford Nanopore Technologies Inc. was awarded a $75,165 firm fixed-price purchase order by a civilian Southeast Area federal agency for a GRIDION X5 Starter Pack, with performance in Gainesville, Florida. The contract was executed on September 18, 2017, with completion required by September 30, 2017. This award represents a procurement of genomic sequencing equipment from Oxford Nanopore Technologies Inc., a biotechnology company specializing in nanopore-based electronic systems for DNA, RNA,...
- Oxford Nanopore Technologies Inc. was awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to deliver GridION software licenses. The solicitation sought GridION software or equal, including device warranty. As a foreign owned for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing systems and supplies consumables to support genomic research. They have provided equipment, reagents, kits and...